Free Access
Issue |
Med Sci (Paris)
Volume 40, Number 3, Mars 2024
Nos jeunes pousses ont du talent !
|
|
---|---|---|
Page(s) | 304 - 307 | |
Section | Partenariat médecine/sciences - Écoles doctorales - Masters | |
DOI | https://doi.org/10.1051/medsci/2024020 | |
Published online | 22 March 2024 |
- Burslem GM, Crews CM. Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery. Cell 2020; 181 : 102–14. [CrossRef] [PubMed] [Google Scholar]
- Hu Z, Crews CM. Recent Developments in PROTAC-Mediated Protein Degradation: From Bench to Clinic. Chembiochem Eur J Chem Biol 2022; 23 : e202100270. [CrossRef] [PubMed] [Google Scholar]
- Memon H, Patel BM. PROTACs: Novel Approach for Cancer Breakdown by Breaking Proteins. Life Sci 2022; 300 : 120577. [CrossRef] [PubMed] [Google Scholar]
- Lei H, Wang W, Wu Y. Targeting Oncoproteins for Degradation by Small Molecules in Myeloid Leukemia. Leuk Lymphoma 2018 ; 59 : 2297–2304. [CrossRef] [PubMed] [Google Scholar]
- Mares A, Miah AH, Smith IED, et al. Extended Pharmacodynamic Responses Observed upon PROTAC-Mediated Degradation of RIPK2. Commun Biol 2020; 3 : 140. [CrossRef] [PubMed] [Google Scholar]
- Bond MJ, Chu L, Nalawansha DA, et al. Targeted Degradation of Oncogenic KRASG12C by VHL-Recruiting PROTACs. ACS Cent Sci 2020; 6 : 1367–75. [CrossRef] [PubMed] [Google Scholar]
- Garbe C, Abusaif S, Eigentler TK. Vemurafenib. Recent Results Cancer Res 2014 ; 201 : 215–225. [CrossRef] [PubMed] [Google Scholar]
- Alabi S, Jaime-Figueroa S, Yao Z, et al. Mutant-Selective Degradation by BRAF-Targeting PROTACs. Nat Commun 2021; 12 : 920. [CrossRef] [PubMed] [Google Scholar]
- Noblejas-López MDM, Nieto-Jimenez C, Burgos M, et al. Activity of BET-Proteolysis Targeting Chimeric (PROTAC) Compounds in Triple Negative Breast Cancer. J Exp Clin Cancer Res 2019 ; 38 : 383. [CrossRef] [PubMed] [Google Scholar]
- Gao X, Burris HA III, Vuky J, et al. Phase 1/2 Study of ARV-110, an Androgen Receptor (AR) PROTAC Degrader, in Metastatic Castration-Resistant Prostate Cancer (mCRPC). J Clin Oncol 2022; 40: 17. [CrossRef] [Google Scholar]
- Békés M, Langley DR, Crews CM. PROTAC Targeted Protein Degraders: The Past Is Prologue. Nat Rev Drug Discov 2022; 21 : 181–200. [CrossRef] [PubMed] [Google Scholar]
- Cecchini C, Pannilunghi S, Tardy S, et al. From Conception to Development: Investigating PROTACs Features for Improved Cell Permeability and Successful Protein Degradation. Front Chem 2021; 9 : 672267. [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.